← back to search

Richard L. Blosser

Johns Hopkins University · US
🔎 Find collaborators in Immunology · Oncology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Immunology · Oncology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Immune cells in cancer, and Immune Cell Function and Interaction.
h-index
20
citations
6,063
works
67
NIH funding
primary concept
email

Recent publications

Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
Nature 2021cited by 534position: middledoi
Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes
Journal for ImmunoTherapy of Cancer 2021cited by 120position: middledoi
Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
Nature 2021cited by 13position: middledoi
Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells
Journal of Clinical Investigation 2020cited by 425position: middledoi
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
Science 2019cited by 1,142position: middledoi
Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non–Small Cell Lung Cancer
Clinical Cancer Research 2019cited by 152position: middledoi
mTOR Complex 1 Signaling Regulates the Generation and Function of Central and Effector Foxp3+ Regulatory T Cells
The Journal of Immunology 2018cited by 140position: middledoi
Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8+ T cell differentiation
Nature Immunology 2016cited by 227position: middledoi
Generation of MANAbodies specific to HLA-restricted epitopes encoded by somatically mutated genes
Proceedings of the National Academy of Sciences 2015cited by 66position: middledoi
The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
Cancer Discovery 2014cited by 1,444position: middledoi
Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
Proceedings of the National Academy of Sciences 2014cited by 673position: middledoi
STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients
Journal of Clinical Investigation 2013cited by 508position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ada Tam · Bloomberg (United States)9 papers (2013–2021)Jiayu Wen · Jinan University4 papers (2016–2020)Min Hee Oh · Dankook University4 papers (2016–2020)Chirag H. Patel · Enzo Life Sciences (United States)4 papers (2016–2020)Jonathan D. Powell · Johns Hopkins Medicine4 papers (2016–2020)Im‐Hong Sun · University of California, San Francisco4 papers (2016–2020)Drew M. Pardoll · Bloomberg (United States)3 papers (2013–2021)Bert Vogelstein · Clinical Pharmacology of Miami3 papers (2014–2015)Nickolas Papadopoulos · Ludwig Cancer Research3 papers (2014–2015)Liang Zhao · Bloomberg (United States)3 papers (2018–2020)Matthew L. Arwood · Johns Hopkins Medicine3 papers (2018–2020)Kenneth W. Kinzler · University of Baltimore3 papers (2014–2015) · 2 papers (2019–2020)Wei Xu · The First Affiliated Hospital, Sun Yat-sen University2 papers (2018–2020)Rana Rais · Johns Hopkins University2 papers (2019–2020)Shibin Zhou · Bloomberg (United States)2 papers (2014–2015)Barbara S. Slusher · Johns Hopkins University2 papers (2019–2020)Robert A. Anders · University of Baltimore2 papers (2014–2021)Andrew D. Skora · Howard Hughes Medical Institute2 papers (2014–2015)Robert D. Leone · Bloomberg (United States)2 papers (2019–2020)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Immunology · Oncology →